CDMO Archives - Journal for Clinical Studies

Current Edition

Volume 13 Issue 6

Integrated CDMO Growth Will Lead to Patients Seeing Record Number of Drugs Making it to Market

It’s undoubtedly a very interesting time for the global CRO industry. This is particularly true for CROs with locations across the world who have been able to leverag...

9 December 2021 Volume 13 Issue 6 Aragen | CDMO

Continue Reading →

Regional News

Samsung plots $205B investment, massive hiring spree to ramp up CDMO, biosimilars and more

With a self-proclaimed “Super Plant” already on the way in South Korea, Samsung Biologics CEO John Rim said in January that the CDMO’s expansion push was just getting...

25 August 2021 Regional News CDMO | investment

Continue Reading →

news

Quotient Sciences Launches as the New Global Identity for Quotient Clinical

Quotient Clinical, the drug development services organization, announces its renaming to Quotient Sciences (Quotient), following the acquisitions of Co-Formulate, QS ...

15 November 2017 news CDMO | clinical trial

Continue Reading →

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Rare Disease Ebook

Vaccine – Shorten Start-Up Timelines in Vaccine Trials

Current Edition

Integrated CDMO Growth Will Lead to Patients Seeing Record Number of Drugs Making it to Market

Samsung plots $205B investment, massive hiring spree to ramp up CDMO, biosimilars and more

Quotient Sciences Launches as the New Global Identity for Quotient Clinical

Journal for Clinical Studies